摘要
目的探讨药品降价政策对解决广大人民群众“看病贵”问题的实际成效。方法采用回顾性方法对17次药品降价和医院人均医疗费用进行统计分析。结果17次药品降价累计降价总额1144.8亿元,而在药品降价的1999—2003年间,人均门诊药费和住院药费平均每年分别增长15.4%和14.5%。结论药品降价不一定能降低门诊药费和住院药费,更不能从根本上解决“看病贵”的问题。
Objectlve To analyze the actual effect of reducing drug price to solve the problem "to see a doctor expensively" for the broad messez. Methods 17 times of reducing drug price and the average medical expense were analyzed statistically with retrospective method. Results The accumulative amount of reducing prices reached 14.48 billion Yuan RMB in 17 times of reducing drug price. From 1999 to 2003, the average drug cost for outpatient,, and inpatients annually increased average 15.4%, 14.5% respectively. Conclusion Reducing drug price dose not necessarily decrease the drug cost for outpatients and inpatients, further, can not essentially settle the problem"to see doctor expensively".
出处
《中国药业》
CAS
2006年第13期51-52,共2页
China Pharmaceuticals
关键词
药品降价
医疗费用
效果分析
reducing drug price
medical expense
effect analysis